RDY

Dr Reddy's Laboratories Limited
D

RDY

14.455
USD
-0.06
(-0.41%)
مغلق
حجم التداول
37,366
الربح لكل سهم
77
العائد الربحي
0.63
P/E
19
حجم السوق
12,031,980,770
التوصيات
Moustafa El khaldy
Moustafa El khaldy
منذ سنة
sell
RDY
RDY @76.07
2024-07-05 05:47
RDY@76.07 Chart
الربح
9,242.25
81.00%
المزيد
أصول ذات صلة
AZN
AZN
-1.320
(-1.63%)
79.650 USD
GSK
GSK
-0.560
(-1.39%)
39.630 USD
LLY
LLY
-16.07
(-2.26%)
695.40 USD
MRK
MRK
-2.040
(-2.33%)
85.330 USD
NVS
NVS
-1.950
(-1.54%)
124.990 USD
PFE
PFE
-0.735
(-2.84%)
25.135 USD
SNY
SNY
-1.200
(-2.34%)
50.150 USD
TEVA
TEVA
-0.355
(-1.92%)
18.120 USD
المزيد
الأخبار المقالات

العنوان: Dr. Reddy's Laboratories Ltd

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.